Research in Africa and Asia
We invest in researchers, large programmes of research and co-funded initiatives in Africa and Asia.
To support this work, and make sure that research has the most possible impact in these regions, we’ve made strengthening research ecosystems in Africa and Asia one of our strategic priorities.
Major Overseas Programmes
Over the past 30 years, we've invested in Major Overseas Programmes (MOPs) in Africa and Asia.
The research programmes:
- are driven by the major health problems in their areas
- aim to train and support the next generation of researchers and research leaders in their regions.
There are five programmes:
- The KEMRI-Wellcome Trust Research Programme, Kenya, was set up in 1989. Its research focus is respiratory diseases, malnutrition, reproductive health and HIV/AIDS.
- The Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Malawi, was set up in 1995. Its research focus is HIV, malaria and TB.
- The Africa Health Research Institute, KwaZulu-Natal, is a new research organisation, set up in July 2016. It combines the efforts of the Africa Centre for Population Health and the KwaZulu-Natal Research Institute for TB-HIV (K-RITH) to tackle HIV, TB and related diseases.
- The Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme, Thailand and Laos, was set up in 1979 by researchers from Mahidol University in Bangkok. We started funding the programme in 2005. It carries out internationally recognised research into tropical diseases.
- The Vietnam Research Programme and Oxford University Clinical Research Unit, Vietnam, was set up in Ho Chi Minh in 1991, then in Hanoi in 2005. It carries out internationally recognised research into infectious diseases.
MOPs have had a significant impact in their regions.
For example, in South East Asia, early clinical trials using artemisinin derivatives showed they were more effective than quinine in the treatment of severe malaria. This led to a global policy recommendation by the World Health Organization to use artemisinin-based combination therapies as the first line treatment for all forms of malaria.
Alliance for Accelerating Excellence in Science in Africa
The Alliance for Accelerating Excellence in Science in Africa (AESA) is an initiative to catalyse long-term health and development progress in Africa.
It was set up in 2015 by the African Academy of Sciences (AAS) and the New Partnership for Africa’s Development Agency (NEPAD) with support from Wellcome, the Bill and Melinda Gates Foundation and the UK Department for International Development (DFID).
The AESA initiative aims to:
- support African-led initiatives in key areas of science, particularly health research relevant to Africa
- foster mentorship and collaborations in science, with policymakers and through public engagement.
Developing Excellence in Leadership and Training in Africa
The Developing Excellence in Leadership and Training in Africa (DELTAS Africa) programme is a scheme funded by Wellcome in partnership with the UK Department for International Development and AESA. Eleven DELTAS awards have been made to leading African researchers to establish cutting-edge research and training programmes across the continent.
We’re currently working to hand over management of the DELTAS Africa awards to AESA.
The Wellcome Trust/DBT India Alliance
The Wellcome Trust/DBT India Alliance is a co-funded initiative between Wellcome and the Department of Biotechnology, Government of India. The Alliance was launched in 2008 and supports future scientific leaders in India through fellowship awards.
MSD-Wellcome Trust Hilleman Laboratories
MSD-Wellcome Trust Hilleman Laboratories, a partnership between Wellcome,Merck Sharp and Doeme Corp, is a not-for-profit vaccine research and development initiative based in India. Hilleman Laboratories complete research into affordable vaccines, to combat disease in low-income countries.
Human Heredity and Health in Africa initiative
The Human Heredity and Health in Africa (H3Africa) initiative aims to improve the health of African populations through the study of the genomics of common diseases. The initiative is co-funded by Wellcome and the National Institutes of Health in the USA.
Investment in science through our funding schemes
We also fund individuals and teams. For example, in Malawi, funded work has led to new ways of screening for TB in people who are HIV positive. This research led to World Health Organization recommendations for TB screening and has the potential to save half a million lives.
Investment in public engagement
Alongside investments in science, we support engagement with the public and policymakers to raise the profile of research and encourage discussion about its impact on society.
For example, we supported:
- the Dharavi Biennale, a vibrant arts festival in Mumbai, which brought together local artists, researchers and the community to explore health challenges faced by residents of the biggest informal settlement in the city
- Health in the Backyard, a community-led media project using digital storytelling methods to explore attitudes and perceptions of risk in communities involved in animal husbandry in rural Vietnam. This work helped these communities engage with Wellcome-funded research at the Major Overseas Programme in Vietnam.